Shares of Rogers Corp. (NYSE:ROG) gained 19.9% in April 2017, according to data from S&P Global Market Intelligence.
So whatThe company reported first-quarter results on April 26, sending share prices nearly 12% higher the next day. Rogers saw 27% year-over-year sales growth and 79% higher earnings, leaving analyst estimates far behind in both cases.
A Rogers engineer, hard at work on next-generation battery materials. Image source: Rogers.
Now whatRogers shares have now gained 72% over the last 52 weeks, trading steadily near all-time highs. The maker of specialized materials used in battery systems and wireless antennas has consistently delivered solid earnings surprises over the last three years, often coupled with equally strong revenue wins.
This company is poised to continue making a killing in several emerging markets, including the Internet of Things and automotive computing. Best of all, Rogers is winning competitive contracts without resorting to pricing discounts. Trailing operating margins have increased from 12.4% to 14.2% over the last four quarters. In other words, clients are choosing Rogers over rival materials providers for other reasons than low prices, such as product quality and dependable ordering and delivery processes.
Hot Low Price Stocks To Buy Right Now: Mastech Holdings, Inc(MHH)
Advisors' Opinion:- [By Joseph Griffin]
Mastech Digital Inc (NYSEAMERICAN:MHH) CFO John J. Cronin sold 12,000 shares of the firm’s stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $10.74, for a total value of $128,880.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Hot Low Price Stocks To Buy Right Now: Bel Fuse Inc.(BELFB)
Advisors' Opinion:- [By Stephan Byrd]
Get a free copy of the Zacks research report on Bel Fuse, Inc. Class B (BELFB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Media coverage about Bel Fuse, Inc. Class B (NASDAQ:BELFB) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bel Fuse, Inc. Class B earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned media coverage about the electronics maker an impact score of 45.9775371402704 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
- [By Motley Fool Transcribing]
Bel Fuse (NASDAQ:BELFB) Q4 2018 Earnings Conference CallFeb. 21, 2019 11:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Bel Fuse (BELFB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Bel Fuse, Inc. Class B (NASDAQ:BELFB) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Sunday.
Hot Low Price Stocks To Buy Right Now: Heska Corporation(HSKA)
Advisors' Opinion:- [By Shane Hupp]
Tygh Capital Management Inc. lessened its stake in Heska Corp (NASDAQ:HSKA) by 73.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 30,061 shares of the medical research company’s stock after selling 81,824 shares during the period. Tygh Capital Management Inc.’s holdings in Heska were worth $3,120,000 at the end of the most recent quarter.
- [By Motley Fool Transcribers]
Heska Corporation (NASDAQ:HSKA)Q4 2018 Earnings Conference CallFeb. 26, 2019, 11:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Ethan Ryder]
Heska (NASDAQ:HSKA)‘s stock had its “buy” rating reiterated by research analysts at Canaccord Genuity in a research report issued to clients and investors on Friday, MarketBeat reports. They presently have a $115.00 price objective on the medical research company’s stock, up from their prior price objective of $100.00. Canaccord Genuity’s price objective would indicate a potential upside of 12.52% from the company’s previous close.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Heska (HSKA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Heska Corp (NASDAQ:HSKA) EVP Nancy Wisnewski sold 2,250 shares of Heska stock in a transaction dated Friday, June 1st. The stock was sold at an average price of $108.20, for a total value of $243,450.00. Following the completion of the transaction, the executive vice president now owns 37,123 shares in the company, valued at $4,016,708.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
No comments:
Post a Comment